论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhang H, Zhao Y, Zheng Y, Kong Q, Lv N, Liu Y, Zhao D, Li J, Ye Y
Received 9 March 2020
Accepted for publication 10 July 2020
Published 10 August 2020 Volume 2020:13 Pages 2761—2772
DOI https://doi.org/10.2147/IDR.S253143
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Sahil Khanna
Purpose: This study aimed to develop and validate a
personalized prediction model of death risk in patients with Acinetobacter baumannii (A. baumannii )
infection and thus guide clinical research and support clinical
decision-making.
Patients and Methods: The development group is comprised of 350 patients with A. baumannii infection
admitted between January 2013 and December 2015 in The First Affiliated
Hospital of Anhui Medical University. Further, 272 patients in the validation
group were admitted between January 2016 and December 2018. The univariate and
multivariate logistic regression analyses were used to determine the
independent risk factors for death with A. baumannii infection. The nomogram prediction
model was established based on the regression coefficients. The discrimination
of the proposed prediction model was evaluated using the area under the curve
(AUC) of the receiver operating characteristic (ROC) curves and decision curve
analysis (DCA). The calibration diagram was used to evaluate the calibration
degree of this model.
Results: The
infectious source, carbapenem-resistant A. baumannii (CRAB), hypoalbuminemia, Charlson
comorbidity index (CCI), and mechanical ventilation (MV) were independent risk
factors for death. The AUC of the ROC curve of the two groups was 0.768 and
0.792, respectively. The net income was higher when the probability was between
30% and 80%, showing a strong discrimination capacity of the proposed model.
The calibration curve swung around the 45° oblique line, indicating a high
degree of calibration.
Conclusion: The
proposed model helped predict the risk of death from A. baumannii infection,
improve the early identification of patients with a higher risk of death, and
guide clinical treatment.
Keywords: Acinetobacter baumannii ,
carbapenem resistance, prediction model, risk factors